EHS
EHS

FDA Clears AI Polyp Detection Device; IBD and Sexual Issues; Stelara in Pregnancy


The FDA cleared the artificial intelligence-assisted Skout polyp detection device for adults undergoing colorectal cancer screening and surveillance, Iterative Scopes announced.

Nexpowder, an endoscopic hemostasis system that improves visibility and control for gastroenterologists treating upper gastrointestinal non-variceal bleeding, also received FDA clearance, Medtronic announced.

Most inflammatory bowel disease (IBD) patients with avascular necrosis had received corticosteroids, a single-center study found, but other risk factors included a history of arthropathy, estrogen use, and osteoporosis. (Inflammatory Bowel Diseases)

Could monitoring cumulative body mass index help identify patients at high risk for non-alcoholic fatty liver disease? (Liver International)

Two Indiana police officers were required to undergo testing for hepatitis C and HIV after a suspect they were taking into custody allegedly spit blood at them and claimed to be infected with the viruses. (NWI Times)

Clinicians should be on the lookout for symptoms of depression and anxiety in patients with IBD experiencing sexual dysfunction, according to researchers in New Zealand. (Inflammatory Bowel Diseases)

The use of ustekinumab (Stelara) was just as safe for pregnant women with IBD as tumor necrosis factor inhibitors or other therapies, a prospective multicenter cohort study showed. (Alimentary Pharmacology & Therapeutics)

According to a retrospective study, 28% of children with severe intestinal failure developed venous thromboembolism (VTE), with a higher number of catheters and earlier gestational age as independent risk factors for VTE. (Journal of Pediatrics)

Australian researchers suggested that there may be a link between duodenal mucosa-associated microbiota, gastric emptying, and functional dyspepsia symptoms. (Gut)

Speaking anonymously, a gastroenterologist offered insight into how Bon Secours Mercy Health in Virginia allegedly exploited the use of a government program aimed at providing cheaper drugs for low-income patients. (Roanoke Times, New York Times)

  • Zaina Hamza is a staff writer for MedPage Today, covering Gastroenterology and Infectious disease. She is based in Chicago.



Source link

EHS
Back to top button